Active Clinical Trials

red-content-divider.png

The Following are Clinical Trials Currently Under Study.

Please note: Most of the studies are opened for patient enrollment while others are not.  

For patients who have been diagnosed with Age Related Macular Degeneration

1.     Alcon
Testing a new investigational drug in the form of an eye drop for patients who have been diagnosed with Wet or Dry AMD 

2.     Acucela
Phase 2b study for patients with Dry AMD specific to Geographic Atrophy. 

3.     Ophthotech
Phase 3 study for patients with Wet AMD using mono therapy.

For patients who have been diagnosed with Alzheimer Disease

Merck
Phase 2/3 study to examine and test for retinal effects and visual changes while being administered disease specific study drug for dementia.

Genetic Studies

GARM II
Study designed to observe and identify the risk factors that contribute to genetic Age Related Macular Degeneration.

eyeGENE
Study designed to assist in Blood/DNA collection for the National Ophthalmic Disease Genotyping and Phenotyping Network.

Closed Enrollment- The following study is no longer accepting patients. 

Diabetic Retinopathy
Regeneron Pharmaceuticals

Edema

This study is for patients who have been diagnosed with Diabetic Macular Edema as a result of diabetes mellitus.    

Attention Patients and Doctors
If you are interested in obtaining more information or would like to enroll in one of these studies, please contact CFR’s Clinical Research Department at clinicalresearch@cfretina.com.